A5041191466- Reproductive Health and Contraception
- Maternal and Perinatal Health Interventions
- Reproductive Health and Technologies
- Global Maternal and Child Health
- Maternal and fetal healthcare
- Adolescent Sexual and Reproductive Health
- Maternal Mental Health During Pregnancy and Postpartum
- Ectopic Pregnancy Diagnosis and Management
- Assisted Reproductive Technology and Twin Pregnancy
- Prenatal Screening and Diagnostics
- Diversity and Career in Medicine
- Pregnancy and preeclampsia studies
- Birth, Development, and Health
- Systemic Lupus Erythematosus Research
- Gestational Diabetes Research and Management
- Grief, Bereavement, and Mental Health
- MicroRNA in disease regulation
- Reproductive System and Pregnancy
- Preterm Birth and Chorioamnionitis
- Sexual function and dysfunction studies
- Child and Adolescent Health
- Pregnancy-related medical research
- Cancer Risks and Factors
- Global Health Workforce Issues
- Herpesvirus Infections and Treatments
Planned Parenthood
2006-2024
Yale University
2012-2023
RELX Group (United States)
2012-2017
University of the Philippines Diliman
2017
RELX Group (United Kingdom)
2012-2017
Physicians for Human Rights
2013
University of Rochester
2004-2012
University of Rochester Medical Center
2001-2010
Strong Memorial Hospital
2008
University of North Carolina at Chapel Hill
2001-2002
OBJECTIVE: To assess obstetrician-gynecologists’ clinical use of the intrauterine device (IUD), their attitudes toward IUD and how they select candidates, to test hypotheses that limited residency training in IUDs, fear litigation, a belief IUDs cause pelvic inflammatory disease decrease use. METHODS: We performed national mailed survey 811 practicing obstetrician-gynecologists obtained from systematic sampling ACOG membership listings IUD. RESULTS: The response rate was 50%. Most...
In Brief OBJECTIVE: Modern intrauterine devices (IUDs) are safe, effective, and reversible, but only 2.1% of U.S. women use IUDs. We aimed to estimate young pregnant women's knowledge METHODS: surveyed 190 women, aged 14–25 years, presenting for prenatal or abortion care about their contraceptive history, plans, knowledge. asked if they had heard IUDs queried them on IUD characteristics. RESULTS: The were, average, 20 years old, 27% education past high school, 47% delivered a child. Half...
Sox2 is expressed by neural stem and progenitor cells, a sox2 enhancer identifies these cells in the forebrains of both fetal adult transgenic mouse reporters. We found that an adenovirus encoding EGFP placed under regulatory control 0.4 kb core selectively identified multipotential self-renewing dissociates human forebrain. Upon EGFP-based fluorescence-activated cell sorting (FACS), E/sox2:EGFP + isolates were propagable for up to 1 year vitro , remained multilineage competent throughout....
Objectives Induction of fetal demise before second‐trimester termination is performed for a number reasons. One method inducing via sonographically guided intracardiac potassium chloride (KCl) injection. We retrospective cohort study to determine the efficacy and safety KCl injection as induced demise. Methods reviewed records from patients who were referred October 2002 2011. excluded undergoing selective reduction in multiple gestations. Procedural complications, dose KCl, failed...
Problem There is a strong correlation between intrauterine bacterial infection and preterm labor. While inflammation common mechanism, certain pathogens may trigger placental apoptosis. TLR 2 activation by gram‐positive peptidoglycan ( PDG ) induces first‐trimester trophoblast apoptosis decreased IL ‐6 secretion. This dependent upon the presence of 1 absence 6 both coreceptors. As 10 also coreceptor, objective this study was to determine its expression function in trophoblast. Method...
What is the effect of pravastatin on antiphospholipid antibody (aPL) modulation human first trimester trophoblast function? Pravastatin does not prevent effects aPL cell function. Antiphospholipid syndrome (APS) associated with recurrent pregnancy loss and late complications, such as pre-eclampsia, owing to direct targeting placenta by aPL. While treatment heparin reduces rate loss, risk for severe pre-eclampsia remains high. Thus, there a need find alternative treatments prenatal management...
Problem Women with antiphospholipid syndrome ( APS ) are at increased risk of recurrent pregnancy loss RPL and preeclampsia. Antiphospholipid antibodies (a PL directly alter trophoblast function. Treatment low molecular weight heparin LMWH reduces the but not Moreover, stimulates sF lt‐1 release, an anti‐angiogenic factor associated Since vitamin D deficiency is preeclampsia, this study sought to determine effect on function in setting a . Method A human first trimester cell line HTR 8)...
In Brief OBJECTIVE To assess obstetrician-gynecologists' clinical use of the intrauterine device (IUD), their attitudes toward IUD and how they select candidates, to test hypotheses that limited residency training in IUDs, fear litigation, a belief IUDs cause pelvic inflammatory disease decrease use. METHODS We performed national mailed survey 811 practicing obstetrician-gynecologists obtained from systematic sampling ACOG membership listings IUD. RESULTS The response rate was 50%. Most...